Sandra Kane-Gill

Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP, is a Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. Additionally, she is the Associate Dean of Faculty Affairs and Programmatic Innovation. She also serves as Professor for the Center for Critical Care Nephrology. In addition to her academic appointments, Dr. Kane-Gill is a Critical Care Medication Safety Pharmacist at the University of Pittsburgh Medical Center in the Department of Pharmacy.

Dr. Kane-Gill received her Bachelor of Science degree in pharmacy from Wayne State University in Detroit, Michigan. She completed a pharmacy practice residency accredited by the American Society of Health-System Pharmacists at West Virginia University Hospital in Morgantown, West Virginia, and earned a Doctorate of Pharmacy degree from the University of Toledo in Toledo, Ohio. Dr. Kane-Gill then pursued her Master of Science degree in Pharmacy Administration with an emphasis on Pharmacoeconomics and Health Outcomes at The Ohio State University in Columbus, Ohio and she completed a critical care fellowship at The Ohio State University. Recently, Dr. Kane-Gill completed a certification program in implementation science through the CTSI online training program at the University of California, San Francisco.

Dr. Kane-Gill’s interests focus on the assessment of clinical, economic and quality outcomes for critically ill patients. Her goal is to build a pharmacovigilance program to identify effective approaches for the detection, prevention, and management of medication errors and adverse drug events as to improve quality of care and patient safety. She led several pharmacoepidemiology evaluations that improved patient safety surveillance systems, prevented medication errors and adverse drug events (ADEs) and used health information technology (clinical decision support systems, telemedicine, simulation) to improve services. She applies implementation science strategies to ensure the adoption of evidence-based medication safety practices. Dr. Kane-Gill is a federally funded researcher serving as Principal Investigator (AHRQ, NIDDK) and Co-Investigator (AHRQ, NCCIH, NLM, Jewish Healthcare Foundation) on several research grants in this area of study.

Her work has been presented at several professional meetings with over 180 invited presentations and 200 abstract presentations. She has published 250 articles and book chapters related to critical care and patient safety. Her endeavors include editing published books on the use of high-risk intravenous medications in special patient populations and drug-induced complications in critically ill patients. She is on the editorial board for Critical Care Medicine and Annals of Pharmacotherapy. Dr. Kane-Gill is an active member of the American College of Clinical Pharmacy (ACCP), and Society of Critical Care Medicine (SCCM). She is a faculty member of the Research and Scholarship Academy of ACCP. In 2022, she held the elected position of President of the Executive Committee for the Society of Critical Care Medicine (SCCM), which is the decision-making body regarding the governance of SCCM. She is a fellow in the American College of Critical Care Medicine and the American College of Clinical Pharmacy.